Efficacy and Safety of Regan Tangjiang for Treating the Common Cold With Wind-heat Syndrome
Condition: Cold Intervention: Drug: Regan Tangjiang Sponsor: Beijing Da-an Bio-technology Co., Ltd. Not yet recruiting - verified March 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 13, 2017 Category: Research Source Type: clinical trials
Efficacy and safety of Lian-Ju-Gan-Mao capsules for treating the common cold with wind-heat syndrome: study protocol for a randomized controlled trial
DiscussionThis trial is a well-designed study according to principles and regulations issued by the China Food and Drug Administration (CFDA). The results will provide high-quality evidence on the efficacy and safety of LJGMC in treating CCWHS and help to optimize the dose for the next phase III clinical trial. Moreover, the protocol presents a detailed and practical methodology for future clinical trials of drugs developed based on TCM.Trial registrationChinese Clinical Trial Registry,ChiCTR-IPR-15006504. Registered on 4 June 2015. (Source: Trials)
Source: Trials - January 4, 2017 Category: Research Source Type: clinical trials
To Evaluate the Efficacy and Safety of 1146A Nasal Spray in Adult Participants With Symptoms of Common Cold
Condition: Common Cold Interventions: Drug: Carbomer 980 (1146A); Other: Placebo Sponsor: GlaxoSmithKline Not yet recruiting - verified December 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 7, 2016 Category: Research Source Type: clinical trials
